A study of Ashwagandha Kshaar on cough in children.

Phase 1/2

Not yet recruiting

• Conditions: Acute upper respiratory infections. Ayurveda Condition: Kaphaj kasa,

• Registration Number: CTRI/2022/03/041521
• Lead Sponsor: Department of Kaumarabhritya Shri Narayan Prasad Awasthi Govt Ayurveda College Raipur C G

Brief Summary

Physiologically *Kapha dosha* is predominant in *balya-awastha*, may cause various *Kaphaj vyadhi* such as *Kphaj kasa. This* is one of the most common disease that affect *Pranvah shrotas* and further health of the child. Acharya Charak has prescribed *Ashwagandha kshaar*in the management of *Kapha avrudha marga Kasa*. Present study is aimed to re-evaluate the effect of *Ashwagandha Kshaar* on *Kaphaj Kasa* (Productive cough). In this study subject will be advised for oral administration of *Ashwagandha kshaar* and dose of administration will be calculated based on Body Surface Area. *Ashwagandha kshaar* will be advised in viscous liquid formwith unequal amount of *Madhu* and *Ghrita* (ratio 3:1)for 20 days and follow-up will be done on every 10 days. Post treatment follow ups will be done in every 15 days for 2 months.Assessment will be done on the basis of subjective and objective criteria adopted for this study.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-03-29
• Study Start: 2022-04-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• 1.Age group 5-15 years.
• 2.Sex- both male and female.
• 3.Patient with symptoms of Kaphaj Kasa.
• 4.Patient with feeling of tiredness, body ache along with wheezing, shortness of breath.
• 5.Subject willing to participate in study after signing consent.

Exclusion Criteria

• 1.Children below 5 years and above 15 years.
• 3.Chronic disorders like Tuberculosis, Heart Disease, COPD [Chronic Obstructive Pulmonary Disease], Pulmonary abscess, Carcinoma, Pleural effusion, Pneumothorax, Status asthmatics, Congenital and genetic malformations.
• 4.Patient on long term medication (Steroids, etc) 5.Patient tested positive for Covid-19.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Kasa vega(Frequency of cough) reduced	At baseline, 10th day and then every 15 day for the period of 2 months.
2.Nisthavati Ghanam Kapham (Productive cough) reduced	At baseline, 10th day and then every 15 day for the period of 2 months.

Secondary Outcome Measures

Name	Time	Method
1. Vaksha Sampurnamiv manyate [Feeling of mucus in chest region] relived	2. Kanthoplepa [Feeling of mucus coating in upper respiratory tract ] relived

Trial Locations

Locations (1)

Shri khudadad Doongaji Government Ayurved Hospital; 🇮🇳 Raipur, CHHATTISGARH, India

Shri khudadad Doongaji Government Ayurved Hospital

🇮🇳Raipur, CHHATTISGARH, India

Dr Lalit Mohan Bhatt

Principal investigator

9690363169

dr.lalit.ayurveda12@gmail.com